Evgen Pharma Share Discussion Threads

[lovewinshatelosses] 29/2/2024 12:19

Another way to look at this could be amazement that there are actually any buyers, given where things stand. Perhaps retail have finally decided not to invest any of their hard earned, when company Directors are not willing to, so a buyers strike, of sorts?
Lots to hate in this space recently too: FARN, VAL, AVCT, HEMO and the one that actually has a commercial product - STX - perhaps the worst stench of them all, at the time of print. The question is: are they all destined for the same fate as 4D and RENE? At least in those examples, both saw decent inside buying, so a degree of alignment was there. Still lots of people looking to sell into any spikes here, as I suggested on the last one. Ideally want to get into a new tax year before offloading the last of this dog; that gives HJ and his band of merry men a last chance to show they have genuine faith in this outfit using a chunk of their rock star salaries to buy shares. Lol. GLA.

[clocktower] 29/2/2024 11:35

Well back to the lows and no love being shown for the last good news.

I wonder how long it will be before we see another declaration of a reduction in holdings of one of the major holders or this just the free float movement?

[clocktower] 28/2/2024 14:57

Sorry wrong thread, I posted by mistake here.

[peverill] 27/2/2024 14:24

Only thing to get this moving is money or a deal involving money.

[clocktower] 27/2/2024 09:09

Did you get caught out this time dave4545?

Still, a lot more buys to sells so that might have been just to shake the early small traders out, and they (the MM) may soon be forced to up the stakes if gkace is correct.

[dave4545] 27/2/2024 09:04

Well the mm's do this everywhere now, spike it on news and sell a lot of size then do not move and the price drifts lower and then they drop the price and see how many that bought first thing sell back to them for a huge profit.

[gkace] 27/2/2024 08:38

"We have shown preliminary signs of anti-tumour activity of SFX-01 in organoids derived from human tumours."

[hatfullofsky] 27/2/2024 08:37

dave - the spread is 1.05 / 1.137 you'll get buyers and sellers

[dave4545] 27/2/2024 08:21

There you go if you want evidence of why it's the worst bear market ever, investors have vanished and replaced by day traders who hold 4 minutes then sell for a loss

31518 pays 1.2639p hold 4 mins and sells for 1.1361p laughable

[dave4545] 27/2/2024 08:12

Depends if the traders can hold for more than 30 mins. I bet the mm's know that too, play the match game with the first in buyers terrified to hold a stock.

[gkace] 27/2/2024 08:05

Big news flying under radar

[manual dexterity] 27/2/2024 07:14

Interesting.

[hatfullofsky] 27/2/2024 07:13

Nice update, early indications in bowel / Colorectal cancer models

[peterm10] 19/2/2024 17:32

Interesting podcast ... Think it's free but sponsored by the New Scientist. Should benefit us minnows https://www.google.com/url?sa=t&source=web&rct=j&opi=89978449&url=https://www.newscientist.com/podcasts/transforming-clinical-trials-episode-1/&ved=2ahUKEwiv9Pq-97eEAxXYUUEAHVW3DNoQFnoECCoQAQ&usg=AOvVaw0MtXkFIPIjssKYBushBPlf

[clocktower] 19/2/2024 13:52

Now is not the time to miss out if your still not holding, as an investment/punt though, as there may well be further steady support dave4545.

While is was wise to let it go on the first spike based on your view, if you do not risk a little now then you could be paying a great deal more, and be looking back and wishing.

Each to their own, good luck.

[dave4545] 19/2/2024 11:44

One for the learning training manual for some.

If a price is weak and then the mm's spike it up 30% on news it's best to back off
and let it go, chances are the traders first in will sell out within 5 minutes and others will follow and price goes to where it started

[the imperialist] 19/2/2024 11:42

Is this the 4.5p news?

[lovewinshatelosses] 19/2/2024 11:41

A few lucky people were able to exit on that spike. Not me and my rump holding, sadly. Back to 1p shortly, IMO. Still, I reckon the BOD will buy huge amounts of shares, just as soon as the window opens for them to do so...any day now, lol! :)

[peterm10] 19/2/2024 11:28

Put a smile on my face

[manual dexterity] 19/2/2024 11:25

RNS Number : 6330D
Evgen Pharma PLC
19 February 2024







Evgen Pharma plc

("Evgen" or "the Company" or "the Group")



Positive update on SFX-01 in vitro Glioblastoma (GBM) studies



Further evidence of SFX-01 activity as seen at other academic centres



Alderley Park, UK - 19 February 2024: Evgen Pharma plc (AIM: EVG), the clinical stage drug development company developing sulforaphane-based medicines for the treatment of multiple diseases, announces that the laboratory of Dr Marjolein Geurts, neuro-oncologist at the Erasmus University Medical Centre has observed continuing activity of SFX-01 in GBM cells.



The in vitro studies, which are supported by a grant awarded by the KWF Dutch Cancer Society for a €1.1m project, are designed to investigate the activity of SFX-01 in preclinical GBM models. This work is to be followed by administration of SFX-01 to patients with GBM in a clinical Investigator Sponsored Study (ISS). The scientific collaboration, which commenced in October 2023, will run for three years, generating data continuously throughout the period.



According to the lead investigator, Dr Marjolein Geurts, neuro-oncologist at Erasmus University Medical Center, "We have seen continued evidence of biological activity in patient-derived glioblastoma tissue."



Dr Huw Jones, CEO of Evgen Pharma said:

"These early data triangulate with those seen by our other academic collaborators in Abbruzzo, Italy and Auckland, New Zealand. This is another major academic group observing these effects in tissue derived from a different population of GBM patients which gives us further confidence of SFX-01's potential as a therapeutic option for glioblastoma, a disease with very high unmet medical needs which is devastating for patients and their carers."



-Ends-



Enquiries

Evgen Pharma plc
Dr Huw Jones, CEO
Toni Hänninen, CFO

Dr Helen Kuhlman, CBO

[phone]
[e-mail]

Cavendish Capital Markets (NOMAD and Broker)
Geoff Nash / Teddy Whiley (Corporate Finance)
Nigel Birks (ECM)

[phone]

Instinctif Partners

Melanie Toyne-Sewell / Jack Kincade

[phone]
[e-mail]

[manual dexterity] 19/2/2024 11:25

Excellent news.

[dave4545] 19/2/2024 11:24

news out flying on L2 traders piling in

I'll have to leave it not paying 1.38p when it was 1.08p minutes earlier mm's are just trying to impale people

[clocktower] 15/2/2024 18:24

Certainly is S.

Hopefully it will get better but no certainty for sure.
Director’s have been misleading saying they wished they could buy shares before the last big announcement that sent it from 3p to 7p and they have never bought since but if hat is correct you never know but I think that’s wishful thinking.

[smithie6] 15/2/2024 15:59

6p to 1p !

Pretty scary chart !

[hatfullofsky] 15/2/2024 13:56

I wouldn't be at all surprised if some of those buys earlier were director buys